AK-001
- Generic Name
- AK-001
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK001
- First Posted Date
- 2015-09-30
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- Allakos Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT02563938
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath